CP and acute myeloid leukemia: Another potential mediator of PCA in AML is cancer procoagulant (CP), a cysteine proteinase that activates factor X independently of factor VIIa (FVIIa) [39], although more recent studies have questioned a predominant role of CP in paraneoplastic coagulation activation [40].